Literature DB >> 15109767

Tocol emulsions for drug solubilization and parenteral delivery.

Panayiotis P Constantinides1, Alex Tustian, Dean R Kessler.   

Abstract

Tocols represent a family of tocopherols, tocotrienols, and their derivatives, and are fundamentally derived from the simplest tocopherol, 6-hydroxy-2-methyl-2-phytylchroman, which is referred to as "tocol". The most common tocol is D-alpha-tocopherol, also known as vitamin E. Tocols can be excellent solvents for water insoluble drugs and are compatible with other cosolvents, oils and surfactants. This review highlights the major developments in the use of tocols in parenteral emulsions for drug delivery, with a focus on drug solubilization, physicochemical properties, and biopharmaceutical applications. Tocol emulsions offer an appealing alternative for the parenteral administration of poorly soluble drugs, including major chemotherapeutics such as paclitaxel. Data will be presented on solubilization of paclitaxel, a key chemotherapeutic agent, and its corresponding formulation development, toxicity, efficacy and pharmacokinetic studies in animal models and humans. The breadth of the utility of tocol-based emulsions will be discussed and examples of specific therapeutic drugs and applications will be provided. As these formulations progress further in the clinic, the therapeutic utility of tocol emulsions is anticipated to expand.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15109767     DOI: 10.1016/j.addr.2003.12.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  16 in total

Review 1.  Injectable lipid emulsions-advancements, opportunities and challenges.

Authors:  Ketan Hippalgaonkar; Soumyajit Majumdar; Viral Kansara
Journal:  AAPS PharmSciTech       Date:  2010-10-26       Impact factor: 3.246

2.  Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability.

Authors:  Bilal S Abuasal; Courtney Lucas; Breanne Peyton; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2012-01-24       Impact factor: 1.880

Review 3.  Advances in the use of tocols as drug delivery vehicles.

Authors:  Panayiotis P Constantinides; Jihong Han; Stanley S Davis
Journal:  Pharm Res       Date:  2006-01-25       Impact factor: 4.200

Review 4.  Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.

Authors:  Mayuri Narvekar; Hui Yi Xue; June Young Eoh; Ho Lun Wong
Journal:  AAPS PharmSciTech       Date:  2014-04-02       Impact factor: 3.246

5.  Intravenous hydrophobic drug delivery: a porous particle formulation of paclitaxel (AI-850).

Authors:  Julie A Straub; Donald E Chickering; Jonathan C Lovely; Huimin Zhang; Bhavdeep Shah; William R Waud; Howard Bernstein
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

6.  Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS).

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2014-06-17       Impact factor: 1.880

7.  Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors.

Authors:  Mohamed Nabil Khalid; Pierre Simard; Didier Hoarau; Alice Dragomir; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2006-03-24       Impact factor: 4.200

8.  Meta-analysis of nanoparticulate paclitaxel delivery system pharmacokinetics and model prediction of associated neutropenia.

Authors:  Sihem Ait-Oudhia; Robert M Straubinger; Donald E Mager
Journal:  Pharm Res       Date:  2012-05-17       Impact factor: 4.200

Review 9.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

10.  Biological evaluation of Safrole oil and Safrole oil Nanoemulgel as antioxidant, antidiabetic, antibacterial, antifungal and anticancer.

Authors:  Ahmad M Eid; Mohammed Hawash
Journal:  BMC Complement Med Ther       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.